Publications by authors named "Philipp Jost"

Claim this Profile
E
Early Detection of Cell Death Using Transmembrane Water Exchange Magnetic Resonance Imaging.
Athanasia Kaika, Luca Nagel, Ulrike Höckendorf, Bangwen Xie, Geoffrey J Topping, Philipp J Jost

Adv Sci (Weinh)· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
1
18 F-FDG PET/CT in NUT Carcinoma of the Thorax.
Anselm Johannes Schlemmer, Gregor Gorkiewicz, Martin Michael Uggowitzer, Spela Salamon, Philipp Jost

Clin Nucl Med· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lymphotoxin alpha eradicates acute myeloid leukemia and simultaneously promotes healthy hematopoiesis in mice.
Ulrike Höckendorf, Sayantanee Dutta, Arnold Kloos, Marah Runtsch, Carina Zötsch, Philipp J Jost

Sci Transl Med· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeting hexokinase 2 to induce breast cancer cell senescence.
Helmut Bischof, Katarina Cisarova, Sandra Burgstaller, Mia Schwerer, Markus Absenger-Novak, Philipp J Jost

Br J Pharmacol· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Arterial thromboembolic events in testicular cancer patients: short- and long-term incidence, risk factors, and impact on mortality.
Florian Moik, Angelika Terbuch, Ariane Sprakel, Georg Pichler, Dominik A Barth, Philipp J Jost

J Thromb Haemost· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical impact of single-gene vs. panel sequencing in advanced HR + /HER2- breast cancer: insights and implications.
Eva Valentina Klocker, Nina Dobrić, Ricarda Graf, Christine Beichler, Dominik Hlauschek, Philipp Jakob Jost

NPJ Breast Cancer· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Platelet mass cytometry reveals dysregulation of prothrombotic pathways in essential thrombocythemia.
Veronika Dill, Kilian Kirmes, Jiaying Han, Melissa Klug, Marc Rosenbaum, Philipp J Jost

Platelets· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Early Change in C-Reactive Protein and Venous Thromboembolism in Patients Treated With Immune Checkpoint Inhibitors.
Florian Moik, Jakob M Riedl, Dominik Barth, Franziska Berton, Michael Fink, Philipp J Jost

JACC CardioOncol· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic impact of targetable driver alterations in resected early-stage lung cancer.
Angelika Terbuch, Selma Konjic, Verena Schlintl, Gudrun Absenger, Philipp J Jost

Transl Lung Cancer Res· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sustained Clinical Benefit and Intracranial Activity of Tarlatamab in Previously Treated Small Cell Lung Cancer: DeLLphi-300 Trial Update.
Afshin Dowlati, Horst-Dieter Hummel, Stephane Champiat, Maria Eugenia Olmedo, Michael Boyer, Philipp J Jost

J Clin Oncol· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Survival of patients with ruptured gastrointestinal stromal tumour treated with adjuvant imatinib in a randomised trial.
Heikki Joensuu, Annette Reichardt, Mikael Eriksson, Peter Hohenberger, Kjetil Boye, Philipp J Jost

Br J Cancer· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Longitudinal analysis of PD-L1 expression in patients with relapsed NSCLC.
Nikolaus John, Verena Schlintl, Teresa Sassmann, Jörg Lindenmann, Melanie Fediuk, Philipp J Jost

J Immunother Cancer· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Author Correction: Proteogenomic analysis reveals RNA as a source for tumor-agnostic neoantigen identification.
Celina Tretter, Niklas de Andrade Krätzig, Matteo Pecoraro, Sebastian Lange, Philipp Seifert, Philipp J Jost

Nat Commun· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Molecular diagnostics tailoring personalized cancer therapy-an oncologist's view.
Jakob M Riedl, Florian Moik, Tamara Esterl, Sarah M Kostmann, Armin Gerger, Philipp J Jost

Virchows Arch· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Expanding Broad Molecular Reflex Testing in Non-Small Cell Lung Cancer to Squamous Histology.
Martin Zacharias, Selma Konjic, Nikolaus Kratochwill, Gudrun Absenger, Angelika Terbuch, Philipp J Jost

Cancers (Basel)· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of radiotherapy on local recurrence, distant metastasis and overall survival in 1200 extremity soft tissue sarcoma patients. Retrospective analysis using IPTW-adjusted models.
Maria A Smolle, Dimosthenis Andreou, Judith Wölfel, Ibtissam Acem, Michiel Aj Van De Sande, Philipp J Jost

Radiother Oncol· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Early kinetics of C reactive protein for cancer-agnostic prediction of therapy response and mortality in patients treated with immune checkpoint inhibitors: a multicenter cohort study.
Dominik A Barth, Florian Moik, Sarah Steinlechner, Florian Posch, Marie-Christina Mayer, Philipp J Jost

J Immunother Cancer· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Incidence of Diabetes Mellitus and Its Impact on Outcomes in Patients Undergoing Surgical Pancreatectomy for Non-Malignant and Malignant Pancreatobiliary Diseases-A Retrospective Analysis.
Anna Schranz, Christoph Sternad, Faisal Aziz, Doris Wagner, Peter Kornprat, Philipp J Jost

J Clin Med· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Transcriptomic profiling does not refine mastocytosis diagnosis.
Lars Buschhorn, Dorett I Odoni, Johanna Geuder, Timo O Odinius, Celina V Wagner, Philipp J Jost

Haematologica· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
K
KIT and PDGFRA Mutations and Survival of Gastrointestinal Stromal Tumor Patients Treated with Adjuvant Imatinib in a Randomized Trial.
Heikki Joensuu, Eva Wardelmann, Mikael Eriksson, Annette Reichardt, Kirsten Sundby Hall, Philipp J Jost

Clin Cancer Res· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Proteogenomic analysis reveals RNA as a source for tumor-agnostic neoantigen identification.
Celina Tretter, Niklas de Andrade Krätzig, Matteo Pecoraro, Sebastian Lange, Philipp Seifert, Philipp J Jost

Nat Commun· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Apoptotic cell death in disease-Current understanding of the NCCD 2023.
Ilio Vitale, Federico Pietrocola, Emma Guilbaud, Stuart A Aaronson, John M Abrams, Philipp J Jost

Cell Death Differ· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development of Highly Sensitive Digital Droplet PCR for Detection of cKIT Mutations in Circulating Free DNA That Mediate Resistance to TKI Treatment for Gastrointestinal Stromal Tumor (GIST).
Michael Rassner, Silvia Waldeck, Marie Follo, Stefanie Jilg, Ulrike Philipp, Philipp J Jost

Int J Mol Sci· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and safety of ruxolitinib in patients with newly-diagnosed polycythemia vera: futility analysis of the RuxoBEAT clinical trial of the GSG-MPN study group.
Steffen Koschmieder, Susanne Isfort, Dominik Wolf, Florian H Heidel, Andreas Hochhaus, Philipp J Jost

Ann Hematol· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tyrosine kinase inhibitors can activate the NLRP3 inflammasome in myeloid cells through lysosomal damage and cell lysis.
Emilia Neuwirt, Giovanni Magnani, Tamara Ćiković, Svenja Wöhrle, Larissa Fischer, Philipp J Jost

Sci Signal· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis